AcelRx Pharmaceuticals (ACRX)

Add to Watchlists Create an Alert
7.86 +0.41  +5.50%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

AcelRx Pharmaceuticals Enterprise Value:

248.90M for May 24, 2013
View Full Chart

AcelRx Pharmaceuticals Enterprise Value Chart

    AcelRx Pharmaceuticals Historical Enterprise Value Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 12   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    May 24, 2013 248.90M
    May 23, 2013 233.63M
    May 22, 2013 226.55M
    May 21, 2013 194.53M
    May 20, 2013 196.76M
    May 17, 2013 204.96M
    May 16, 2013 223.95M
    May 15, 2013 221.34M
    May 14, 2013 220.59M
    May 13, 2013 191.92M
    May 10, 2013 190.43M
    May 9, 2013 183.73M
    May 8, 2013 175.91M
    May 7, 2013 192.29M
    May 6, 2013 180.38M
    May 3, 2013 171.81M
    May 2, 2013 173.30M
    May 1, 2013 162.88M
    April 30, 2013 174.42M
    April 29, 2013 175.91M
    April 26, 2013 174.79M
    April 25, 2013 175.91M
    April 24, 2013 180.38M
    April 23, 2013 185.22M
    April 22, 2013 175.54M
       
    April 19, 2013 174.42M
    April 18, 2013 165.11M
    April 17, 2013 159.90M
    April 16, 2013 163.25M
    April 15, 2013 171.44M
    April 12, 2013 180.75M
    April 11, 2013 179.63M
    April 10, 2013 162.13M
    April 9, 2013 161.76M
    April 8, 2013 151.71M
    April 5, 2013 143.51M
    April 4, 2013 138.67M
    April 3, 2013 141.28M
    April 2, 2013 140.16M
    April 1, 2013 139.05M
    March 28, 2013 147.44M
    March 27, 2013 149.66M
    March 26, 2013 150.03M
    March 25, 2013 150.40M
    March 22, 2013 153.37M
    March 21, 2013 139.66M
    March 20, 2013 130.39M
    March 19, 2013 123.35M
    March 18, 2013 130.76M
    March 15, 2013 127.43M

    About Enterprise Value

    Click "Learn More" below to see how YCharts calculates Enterprise Value.

    Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

    EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
    Learn More

    Get data for

    ACRX Enterprise Value Benchmarks

    Companies
    Astex Pharmaceuticals 365.02M
    Cyanotech Corporation 30.03M
    Intercept Pharmaceuticals 467.16M

    ACRX Enterprise Value Rankings

    Overall 58th percentile
    3142 of 7600
    Sector 53rd percentile
    302 of 653 in Healthcare
    Industry 58th percentile
    22 of 53 in Drug Manufacturers - Major

    ACRX Enterprise Value Range, Past 5 Years

    Minimum 14.40M Dec 30 2011
    Maximum 248.90M May 24 2013
    Average 71.52M